Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection
Open Access
- 2 May 2020
- journal article
- case report
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 5 (2), 69
- https://doi.org/10.3390/tropicalmed5020069
Abstract
The influence of antimoniate treatment on specific anti-protozoan T-cell responses was evaluated in a 48-year-old male patient diagnosed with mucosal leishmaniasis and Chagas disease infection. Before and after treatment, PBMC (peripheral blood mononuclear cells) were cultured in the absence or presence of Leishmania braziliensis or Trypanosoma cruzi live parasites, their soluble antigens, or PHA (phytohaemagglutinin). Cytokines were measured and Treg (T regulatory) cell percentages were quantified. Before treatment, PBMC were able to produce higher amounts of TNF-α, IL-6 (Interleukin-6), and IL-10 (Interleukin-10) but lower amounts of IL-12 (Interleukin-12) in response to culture stimulation. However, after treatment, there was a down-modulation of TNF-α, IL-6, and IL-10 cytokines but an up-modulation in IL-12 production. PBMC had the ability to produce TNF-α only against live parasites or PHA. There was an overall decrease of circulating Treg cells after treatment. In mixed Leishmaniasis and Chagas disease infection, treatment with antimoniate could modulate immune responses toward a more protective profile to both diseases.Keywords
This publication has 26 references indexed in Scilit:
- Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' DiseasePLoS Neglected Tropical Diseases, 2012
- In SituExpression of Regulatory Cytokines by Heart Inflammatory Cells in Chagas' Disease Patients with Heart FailureClinical and Developmental Immunology, 2012
- Genetic and Functional Role of TNF-alpha in the Development Trypanosoma cruzi InfectionPLoS Neglected Tropical Diseases, 2011
- Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ productionHuman Immunology, 2009
- IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmaniainduced IFN-γ productionBMC Infectious Diseases, 2007
- Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involvedParasitology, 2003
- T-Cell-Mediated Immune Responses in Patients with Cutaneous or Mucosal Leishmaniasis: Long-Term Evaluation after TherapyClinical and Vaccine Immunology, 2002
- Differential Serodiagnosis of Human Infections Caused by Trypanosoma cruzi and Leishmania spp. Using ELISA with a Recombinant Antigen (rTc24)Memórias do Instituto Oswaldo Cruz, 1997
- High correlation between Chagas' disease serology and PCR-based detection ofTrypanosoma cruzikinetoplast DNA in Bolivian children living in an endemic areaFEMS Microbiology Letters, 1994
- Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6)Clinical and Experimental Immunology, 1994